Prospects for PBM reform in 2025 look good
As the new year gets under way, the pharmacy sector has a legitimate shot at making meaningful progress toward realizing that ambitious goal of PBM reform.
Opinion
CHPA’s Melville: O-T-Cs are essential self-care avenue
By Scott Melville, President, and CEO of the Consumer Healthcare Products Association
2025 Health Care Outlook: Sheila Arquette, NASP
By Sheila Arquette, President and CEO, National Association of Specialty Pharmacy (NASP)
2025 Health Care Outlook: John O'Brien, NPC
By John O’Brien, president and CEO of the National Pharmaceutical Council.
2025 Health Care Outlook: Susan Cantrell, AMCP
By Susan Cantrell, Susan Cantrell CEO, Academy of Managed Care Pharmacy.
2025 Health Care Outlook: Peter Matz, FMI
By Peter Matz, Director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
2025 Health Care Outlook: Michael Hogue, APhA
By Michael Hogue, CEO, American Pharmacists Association
2025 Health Care Outlook: Ronald Piervincenzi, USP
By Ronald Piervincenzi, CEO, U.S. Pharmacopeia
2025 Health Care Outlook: Lee Ann Stember, NCPDP
By Lee Ann Stember, President, CEO National Council for Prescription Drug Programs
2025 Health Care Outlook: Chip Davis, HDA
By Chester ‘Chip’ Davis, President and CEO Healthcare Distribution Alliance (HDA).
2025 Health Care Outlook: B. Douglas Hoey, NCPA
By B. Douglas Hoey, CEO, National Community Pharmacists Association
2025 Health Care Outlook: Steve Anderson, NACDS
By Steve Anderson, President, CEO National Association of Chain Drug Stores
Drug chains forge ahead amid uncertainty
It’s fair to say that the chain drug industry is at a turning point.